Skip to content
Open access

Functional role of skull lymphoid structures in CNS immunosurveillance

Aug 2026 · Nature · Vol 658, pp. 196 - 204 · 4 citations · 61 references
Medicine

TL;DR

Functional lymphoid structures within the skull bone marrow enable central nervous system immunosurveillance and shape immune responses to brain disease.

Abstract

Accumulating evidence demonstrates that the central nervous system (CNS) is not disconnected from the peripheral immune system; however, precisely how the adaptive immune system surveils the CNS remains a critical question. Recent findings reveal that channels between the skull and the dura mater facilitate the exchange of cerebrospinal fluid and immune cells between the CNS and skull bone marrow of mice under both homeostatic and disease conditions1, 2, 3, 4, 5–6. Skull bone marrow functions as a source of immune cells for the CNS5, yet its role in CNS antigen-specific adaptive immune responses remains unclear. Here we identify lymphoid structures within the skull bone marrow, featuring germinal-centre-like formations and containing a distinct population of follicular-helper-like T cells that promote B cell activation and humoral immunity through CD40L, IL-21 and IFNγ signalling. Adaptive immune cells within these skull bone marrow lymphoid structures surveil and respond to CNS-derived antigens and contribute to anti-tumour immune responses in mouse brain cancer models. Together, our findings show that the skull bone marrow is a site of CNS immunosurveillance that may influence immune responses across diverse neurological diseases. Functional lymphoid structures within the skull bone marrow enable central nervous system immunosurveillance and shape immune responses to brain disease.

Read PDF

Similar papers

Review Open access Sep 2026

Group 2 innate lymphoid cells: cellular interfaces in neural–immune crosstalk

Recent advances regarding the pivotal role of ILC2s in neural-immune crosstalk are summarized, the pathophysiological consequences of neuro–ILC2 axis dysregulation are discussed, and emerging therapeutic strategies targeting these cellular interfaces for the treatment of inflammatory, allergic, and neurological disease...

Qiang Liu, Jie Zhou · 0 citations
Open access Oct 2026

CNS localization drives a profoundly immunosuppressive microenvironment in B‑cell lymphoma

Primary central nervous system lymphoma (PCNSL) has significantly poorer outcomes than peripheral diffuse large B-cell lymphoma, suggesting need for novel therapies and a deeper understanding of the unique tumor immune microenvironment (TIME) within the brain. To investigate these CNS‑specific immune features, we estab...

J. Niemi, Oscar Badillo-Godinez, M. Hellström · 0 citations
Review Open access Sep 2026

The brain’s immune code: decoding antigen presentation at the meningeal-glymphatic interface in neurological disorders

The classical view of central nervous system (CNS) immune privilege has evolved from isolation to regulated crosstalk. Perivascular cerebrospinal fluid-interstitial fluid transport and meningeal lymphatic vessels (mLVs) move brain-derived molecules toward immune-rich border tissues and cervical lymph nodes, where antig...

Wan-Ying Li, Yu-Ying Liang, Li-Wei Li et al. · 0 citations
Open access Oct 2026

Activation of Innate and Adaptive Immunity in the Central Nervous System Following Xenogeneic Mesenchymal Stromal Cell Transplantation

Stem cell-based therapies have emerged as promising strategies for neurodegenerative disorders, partly supported by the concept of central nervous system immune privilege, which has encouraged xenogeneic transplantation approaches under the assumption of limited host immune responses. However, the immunological consequ...

María Norte-Muñoz, Joaquín Cantón-Sandoval, Fernando Lucas-Ruiz et al. · 0 citations
Review Open access Oct 2026

Neuroimmune communication: from CNS-resident cell networks to the glioblastoma microenvironment

Neurons, glial cells, and immune cells engage in extensive bidirectional communication within the central nervous system (CNS) through shared receptors, ligands, and secreted mediators. Glial cells — particularly astrocytes and microglia — serve not merely as structural support but as central immunomodulatory hubs that...

Yan-Fei Li, Qiu-Hong Zheng, Xian-Wu Wang et al. · 0 citations
Open access Sep 2026

Anti-CD40L prevents meningeal B cell aggregates and mitigates progressive autoimmune encephalomyelitis.

Anti-CD40L treatment may be an effective intervention to mitigate progressive immunopathology associated with meningeal TLS, and modulates and likely silences other CD40-dependent antigen-presenting cells in the CNS, including myeloid cells and astrocyte subsets.

Sofia Tyystjärvi, Diego Ruiz Navarro, Leni-Mihaela Kulisch et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.